Active surveillance in young patients with prostate cancer: The unanswered question

Journal of Clinical Oncology

Volumn 28, Issue 13, 2010, Pages

  Campodonico, Fabio ^a   Maffezzini, Massimo ^a  

^a GALLIERA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; FOLLOW UP; GLEASON SCORE; HUMAN; LETTER; NOMOGRAM; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RELIABILITY; AGE; AGED; BIOPSY; BLOOD; CANCER STAGING; MALE; NOTE; PATIENT SELECTION; PROSTATE TUMOR; TIME; TREATMENT OUTCOME;

AGE FACTORS; AGED; BIOPSY; HUMANS; MALE; NEOPLASM STAGING; PATIENT SELECTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952309177     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.27.3383     Document Type: Letter

References (4)

1. Klotz L, Zhang L, Nam R, et al: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 28:126-131, 2010
2. Prostate Cancer Research International: Active Surveillance. https://www.prias-project.org
3. Remzi M, Frong YK, Dobrovits M, et al: The Vienna nomogram: Validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol 174:1256-1260, 2005 (Pubitemid 41318696)
4. Chang JJ, Shinohara K, Bhargava V, et al: Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 160:2111-2114, 1998 (Pubitemid 128703624)